Document Preview Unavailable

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study

Monge, Susana; Humphreys, James; Nicolay, Nathalie; Braeye, Toon; Izaak Van Evercooren; et al.  Influenza and Other Respiratory Viruses Vol. 18, Iss. 4,  (Apr 2024).

You might have access to this document